Recent studies are showing that a new class of drug which targets a growth factor on nerves is promising for relief of chronic back pain and pain from arthritis.  The medication, called tanezumab, is given by systemic injection and results in improvement of pain lasting many months.  Although further investigation about possible side effects is ongoing, this new type of treatment promises to be a future option for millions of chronic pain sufferers.  New classes of medications to relieve chronic pain are sorely needed as many currently available drugs have side effects of sedation, dizziness, or risks of addiction.

More details can be found here.

Providing cutting-edge fibromyalgia and chronic pain treatment means following the latest scientific developments and studies.  A recent article published by Standford Med may help you understand the integration of cutting-edge and alternative therapies.  You can reach this full article by Emily Hite Stanford Med Article.

If you or a loved one is suffering from chronic pain or a neurological disorder, new and alternative treatments may help you.  For more information, contact Robert J. Friedman, M.D. at 561-842-7246 or visit www.palmbeachpain.com 

There is intense ongoing research into the mechanisms of tDCS effects on chronic pain and other neurological conditions.

In fact, in recent studies, tDCS was found to change the opioid receptor (brain chemical system that is activated by painkiller medications) activity and to increase the pain threshold.

For further information, click on this link for the full article from the journal Frontiers in Psychiatry.

To learn if tDCS or other new or alternative treatments are right for you, please contact Dr. Friedman at 561-842-PAIN (7246).